A subset of dysregulated metabolic and survival genes is associated with severity of hepatic steatosis in obese Zucker rats

被引:67
作者
Buque, Xabier [1 ]
Jose Martinez, Maria [1 ]
Cano, Ainara [1 ]
Miquilena-Colina, Maria E. [2 ,3 ]
Garcia-Monzon, Carmelo [2 ,3 ]
Aspichueta, Patricia [1 ]
Ochoa, Begona [1 ]
机构
[1] Univ Basque Country, Sch Med, Dept Physiol, Bilbao, Spain
[2] Univ Hosp Santa Cristina, Liver Res Unit, Madrid, Spain
[3] Univ Hosp Santa Cristina, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
关键词
gene expression; lipid synthesis; triglyceride secretion; FATTY LIVER-DISEASE; INSULIN-RESISTANCE; NONALCOHOLIC STEATOHEPATITIS; UP-REGULATION; PROTEIN; CARBOHYDRATE; EXPRESSION; SECRETION; SREBP-1C; PATHWAY;
D O I
10.1194/jlr.M001966
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We aimed to characterize the primary abnormalities associated with fat accumulation and vulnerability to hepatocellular injury of obesity-related fatty liver. We performed functional analyses and comparative transcriptomics of isolated primary hepatocytes from livers of obese insulin-resistant Zucker rats (comprising mild to severe hepatic steatosis) and age-matched lean littermates, searching for novel genes linked to chronic hepatic steatosis. Of the tested genome, 1.6% was identified as steatosis linked. Overexpressed genes were mainly dedicated to primary metabolism (100%), signaling, and defense/acute phase (similar to 70%); detoxification, steroid, and sulfur metabolism (similar to 65%) as well as cell growth/proliferation and protein synthesis/transformation (similar to 70%) genes were downregulated. The overexpression of key genes involved in de novo lipogenesis, fatty acid and glycerolipid import and synthesis, as well as acetyl-CoA and cofactor provision was paralleled by enhanced hepatic lipogenesis and production of large triacylglycerol-rich VLDL. Greatest changes in gene expression were seen in those encoding the lipogenic malic enzyme (up to 7-fold increased) and cell-to-cell interacting cadherin 17 (up to 8-fold decreased). Among validated genes, fatty acid synthase, stearoyl-CoA desaturase 1, fatty acid translocase/Cd36, malic enzyme, cholesterol-7 alpha hydroxylase, cadherin 17, and peroxisome proliferator-activated receptor alpha significantly correlated with severity of hepatic steatosis. In conclusion, dysregulated expression of metabolic and survival genes accompany hepatic steatosis in obese insulin-resistant rats and may render steatotic hepatocytes more vulnerable to cell injury in progressive nonalcoholic fatty liver disease.-Buque, X., M. J. Martinez, A. Cano, M. E. Miquilena-Colina, C. Garcia-Monzon, P. Aspichueta, and B. Ochoa. A subset of dysregulated metabolic and survival genes is associated with severity of hepatic steatosis in obese Zucker rats. J. Lipid Res. 2010. 51: 500-513.
引用
收藏
页码:500 / 513
页数:14
相关论文
共 43 条
[1]   The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies [J].
Adams, LA ;
Sanderson, S ;
Lindor, KD ;
Angulo, P .
JOURNAL OF HEPATOLOGY, 2005, 42 (01) :132-138
[2]   Overproduction of large VLDL particles is driven by increased liver fat content in man [J].
Adiels, M ;
Taskinen, MR ;
Packard, C ;
Caslake, MJ ;
Soro-Paavonen, A ;
Westerbacka, J ;
Vehkavaara, S ;
Hakkinen, A ;
Olofsson, SO ;
Yki-Jarvinen, H ;
Borén, J .
DIABETOLOGIA, 2006, 49 (04) :755-765
[3]  
Alemzadeh R, 2005, MED SCI MONITOR, V11, pBR439
[4]   Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[5]   Endotoxin promotes preferential periportal upregulation of VLDL secretion in the rat liver [J].
Aspichueta, P ;
Pérez, S ;
Ochoa, B ;
Fresnedo, O .
JOURNAL OF LIPID RESEARCH, 2005, 46 (05) :1017-1026
[6]   PPARs: therapeutic targets for metabolic disease [J].
Berger, JP ;
Akiyama, TE ;
Meinke, PT .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (05) :244-251
[7]   Molecular mediators of hepatic steatosis and liver injury [J].
Browning, JD ;
Horton, JD .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (02) :147-152
[8]   Insulin resistance: A metabolic pathway to chronic liver disease [J].
Bugianesi, E ;
McCullough, AJ ;
Marchesini, G .
HEPATOLOGY, 2005, 42 (05) :987-1000
[9]   Complications of cirrhosis III. Hepatic encephalopathy [J].
Butterworth, RE .
JOURNAL OF HEPATOLOGY, 2000, 32 :171-180
[10]   LIVER ACETYL COA CARBOXYLASE AND FATTY ACID SYNTHETASE - RELATIVE ACTIVITIES IN NORMAL STATE AND IN HEREDITARY OBESITY [J].
CHANG, HC ;
SEIDMAN, I ;
TEEBOR, G ;
LANE, MD .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1967, 28 (05) :682-&